Malnutrition and pharmacokinetics of penicillin in Ethiopian children

P Bolme1, M Eriksson, L Paalzow

  • 1Ethio-Swedish Children's Hospital, Addis Ababa, Ethiopia.

Insights

Malnourished children show reduced penicillin clearance, impacting oral bioavailability. Oral penicillin doses should be increased for fasting, severely ill children to ensure effective treatment.

Area of Science:

  • Pharmacokinetics
  • Pediatrics
  • Nutritional Science

Background:

  • Nutritional status significantly influences drug metabolism and efficacy.
  • Penicillin is a critical antibiotic for pediatric infections.
  • Understanding drug pharmacokinetics in malnutrition is vital for treatment optimization.

Purpose of the Study:

  • To investigate the effect of nutritional status on penicillin pharmacokinetics in children.
  • To compare penicillin plasma concentrations across different nutritional groups (normal, underweight, marasmus, kwashiorkor).
  • To evaluate the impact of administration route and fasting state on penicillin bioavailability.

Main Methods:

  • Administered penicillin intravenously, intramuscularly, or orally to 104 children with varying nutritional status.
  • Monitored plasma penicillin concentrations at regular intervals post-administration.
  • Analyzed pharmacokinetic parameters including plasma clearance, half-life, and volume of distribution.

Main Results:

  • Significantly decreased plasma clearance of penicillin observed in all malnourished groups compared to normal weight-for-age children.
  • Penicillin half-life remained unchanged across nutritional groups due to a decreased volume of distribution in malnourished children.
  • Oral penicillin bioavailability was reduced in non-fasting individuals, with the most pronounced effect in children with marasmus and kwashiorkor.

Conclusions:

  • Nutritional status significantly alters penicillin pharmacokinetics, primarily affecting plasma clearance and bioavailability.
  • Oral penicillin administration in severely malnourished children requires dose adjustment and should ideally occur during fasting.
  • Optimized dosing strategies are crucial for effective penicillin therapy in undernourished pediatric populations.

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...